Subgroup Analysis Of Patients (Pts) With Her2-Low Metastatic Breast Cancer (Mbc) With Brain Metastases (Bms) At Baseline From Destiny-Breast04, A Randomized Phase III Study Of Trastuzumab Deruxtecan (T-Dxd) Vs Treatment Of Physician'S Choice (Tpc)
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Subgroup Analysis Of Patients (Pts) With Her2-Low Metastatic Breast Cancer (Mbc) With Brain Metastases (Bms) At Baseline From Destiny-Breast04, A Randomized Phase III Study Of Trastuzumab Deruxtecan (T-Dxd) Vs Treatment Of Physician'S Choice (Tpc) ### Output: Trastuzumab Deruxtecan